InnoCare Pharma Limited
INCPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$452,593 | -$644,206 | -$893,727 | -$20,121 |
| Dep. & Amort. | $106,260 | $92,621 | $68,403 | $32,482 |
| Deferred Tax | $0 | $0 | $328,731 | $41,078 |
| Stock-Based Comp. | -$10,792 | $65,103 | $129,477 | $126,444 |
| Change in WC | -$18,067 | -$243,886 | -$75,100 | $119,525 |
| Other Non-Cash | $9,641 | $59,028 | -$123,338 | -$132,350 |
| Operating Cash Flow | -$365,551 | -$671,340 | -$565,554 | $167,058 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$77,514 | -$254,544 | -$370,327 | -$167,069 |
| Net Acquisitions | $0 | $1,152 | -$20,000 | -$868 |
| Inv. Purchases | -$5,804,595 | -$4,129,314 | -$1,824,370 | -$4,248,940 |
| Inv. Sales/Matur. | $6,993,950 | $5,043,869 | $413,372 | $2,691,035 |
| Other Inv. Act. | -$717 | $5,751 | $74,971 | -$4,123 |
| Investing Cash Flow | $1,111,124 | $666,914 | -$1,726,354 | -$1,729,965 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $163,900 | $31,300 | $325,000 | $50,000 |
| Stock Issued | $18,500 | $9,947 | $2,923,230 | $2,527,459 |
| Stock Repurch. | -$13,354 | -$6,300 | $0 | $0 |
| Dividends Paid | -$362,925 | -$1,153 | $0 | $0 |
| Other Fin. Act. | -$91,716 | -$32,486 | -$153,724 | -$32,652 |
| Financing Cash Flow | -$285,595 | $1,308 | $3,094,506 | $2,544,807 |
| Forex Effect | $16,925 | $25,698 | $139,902 | -$45,297 |
| Net Chg. in Cash | $476,903 | $22,580 | $942,500 | $936,603 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,202,564 | $4,179,984 | $3,237,484 | $2,300,881 |
| End Cash | $4,679,467 | $4,202,564 | $4,179,984 | $3,237,484 |
| Free Cash Flow | -$443,782 | -$925,995 | -$935,881 | -$11 |